Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

FDA accepts NDA for tacrolimus ointment

Nov. 16, 1999

Chromanone derivatives for androgen-dependent and other disorders disclosed by Novartis

Nov. 16, 1999

FDA authorizes OrthoLogic to proceed with Chrysalin trials in fracture healing

Nov. 16, 1999

Candidate treatment for atopic dermatitis presented at Japanese congress

Nov. 2, 1999

PDE4-inhbitory pyridines disclosed by Janssen

Oct. 27, 1999

Polyethoxylated retinamides superior to known retinoic acid derivatives for skin aging

Oct. 25, 1999

Wound-healing agent reaches the market in U.K.

Oct. 25, 1999

FDA okays new antipsoriatic for clinical testing

Oct. 22, 1999

Retinoid receptor-active compounds from Galderma for skin disorders

Oct. 21, 1999

Vasogen cleared to proceed with psoriasis clinical trial

Oct. 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...